0001179110-17-006246.txt : 20170428 0001179110-17-006246.hdr.sgml : 20170428 20170428150311 ACCESSION NUMBER: 0001179110-17-006246 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170426 FILED AS OF DATE: 20170428 DATE AS OF CHANGE: 20170428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Onconova Therapeutics, Inc. CENTRAL INDEX KEY: 0001130598 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-759-3681 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC DATE OF NAME CHANGE: 20001226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kumar Ramesh CENTRAL INDEX KEY: 0001580074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36020 FILM NUMBER: 17794693 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 4 1 edgar.xml FORM 4 - X0306 4 2017-04-26 0 0001130598 Onconova Therapeutics, Inc. ONTX 0001580074 Kumar Ramesh C/O ONCONOVA THERAPEUTICS, INC. 375 PHEASANT RUN NEWTOWN PA 18940 1 1 0 0 President and CEO Common Stock 2017-04-26 4 P 0 23810 2.10 A 102227 D 37,510 shares are held by the Ramesh Kumar 2012 Trust, of which the reporting person is a trustee. /s/ Mark Guerin as attorney-in-fact 2017-04-28